Ausgabe 1/2016
Inhalt (20 Artikel)
Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary
Hideki Takeuchi, Toshiaki Saeki, Keisuke Aiba, Kazuo Tamura, Kenjiro Aogi, Kenji Eguchi, Kenji Okita, Yoshikazu Kagami, Ryuhei Tanaka, Kazuhiko Nakagawa, Hirofumi Fujii, Narikazu Boku, Makoto Wada, Tatsuo Akechi, Yasuhiro Udagawa, Yutaka Okawa, Yusuke Onozawa, Hidenori Sasaki, Yasuo Shima, Naohito Shimoyama, Masayuki Takeda, Toshihiko Nishidate, Akifumi Yamamoto, Tadashi Ikeda, Koichi Hirata
Fraud in clinical trials: complex problem, simple solutions?
Junichi Sakamoto, Marc Buyse
Research misconduct and data fraud in clinical trials: prevalence and causal factors
Stephen L. George
Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan
Tomomi Egawa-Takata, Yutaka Ueda, Akiko Morimoto, Yusuke Tanaka, Shinya Matsuzaki, Eiji Kobayashi, Kiyoshi Yoshino, Masayuki Sekine, Takayuki Enomoto, Tadashi Kimura
Evaluation of the clinical value of carbon nanoparticles as lymph node tracer in differentiated thyroid carcinoma requiring reoperation
Zhang Chaojie, Lei Shanshan, Zhang Zhigong, He Jie, Xiao Shuwen, Fan Peizhi, Xie Jing, Gu Xiaowen, Li Yang, Zheng Wei
Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201
Kiichiro Ninomiya, Katsuyuki Hotta, Akiko Hisamoto-Sato, Eiki Ichihara, Hiroko Gotoda, Daisuke Morichika, Tomoki Tamura, Hiroe Kayatani, Daisuke Minami, Toshio Kubo, Masahiro Tabata, Mitsune Tanimoto, Katsuyuki Kiura
Effects of neutropenia and histological responses in esophageal squamous cell carcinoma with neo-adjuvant chemotherapy
Hirotaka Konishi, Hitoshi Fujiwara, Atsushi Shiozaki, Hidekazu Hiramoto, Toshiyuki Kosuga, Shuhei Komatsu, Daisuke Ichikawa, Kazuma Okamoto, Eigo Otsuji
Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801)
Keisuke Miwa, Eiji Oki, Yasunori Emi, Hiroshi Saeki, Tetsuya Kusumoto, Yoshito Akagi, Yutaka Ogata, Hironori Samura, Shoji Tokunaga, Hiroshi Ishikawa, Takaho Tanaka, Susumu Sueyoshi, Hidefumi Higashi, Hiroyuki Matsuda, Tetsuo Touyama, Yoshihiko Maehara
Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy
Tadayuki Kou, Masashi Kanai, Michio Yamamoto, Peng Xue, Yukiko Mori, Yasushi Kudo, Akira Kurita, Norimitsu Uza, Yuzo Kodama, Masanori Asada, Michiya Kawaguchi, Toshihiko Masui, Masaki Mizumoto, Shujiro Yazumi, Shigemi Matsumoto, Kyoichi Takaori, Satoshi Morita, Manabu Muto, Shinji Uemoto, Tsutomu Chiba
Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis
Kenji Omae, Tsunenori Kondo, Takafumi Kennoki, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe
Clinical outcome of urachal cancer in Japanese patients
Tatsuro Hayashi, Takeshi Yuasa, Sho Uehara, Yasushi Inoue, Shinya Yamamoto, Hitoshi Masuda, Yasuhisa Fujii, Iwao Fukui, Junji Yonese
Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥75 years after radical cystectomy for treatment of bladder cancer
Takahiko Hara, Hideyasu Matsuyama, Yoriaki Kamiryo, Shigeaki Hayashida, Norio Yamamoto, Takahito Nasu, Keiji Joko, Yoshikazu Baba, Akinobu Suga, Mitsutaka Yamamoto, Akihiko Aoki, Kimio Takai, Satoru Yoshihiro, Motohiko Konishi, Sigeru Sakano, Katsuhiko Imoto, Yasuhide Tei, Shiro Yamaguchi, Seiji Yano
Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer
Takashi Mizowaki, Yoshiki Norihisa, Kenji Takayama, Itaru Ikeda, Haruo Inokuchi, Kiyonao Nakamura, Tomomi Kamba, Takahiro Inoue, Toshiyuki Kamoto, Osamu Ogawa, Masahiro Hiraoka
Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma
Haruo Inokuchi, Takashi Mizowaki, Yoshiki Norihisa, Kenji Takayama, Itaru Ikeda, Kiyonao Nakamura, Mitsuhiro Nakamura, Masahiro Hiraoka
Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies
Masatomo Nishikawa, Hideaki Miyake, Masato Fujisawa
Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group
Kenichi Harano, Akihiro Hirakawa, Mayu Yunokawa, Toshiaki Nakamura, Toyomi Satoh, Tadaaki Nishikawa, Daisuke Aoki, Kimihiko Ito, Kiyoshi Ito, Toru Nakanishi, Nobuyuki Susumu, Kazuhiro Takehara, Yoh Watanabe, Hidemichi Watari, Toshiaki Saito
Use of warm Ringer’s lactate solution in the management of locally advanced giant cell tumor of bone
Saranatra Waikakul, Apichat Asavamongkolkul, Rapin Phimolsarnti
Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma
Hidetatsu Outani, Kenichiro Hamada, Yoshinori Imura, Kazuya Oshima, Tsukasa Sotobori, Yusuke Demizu, Shigeki Kakunaga, Susumu Joyama, Reiko Imai, Tomoaki Okimoto, Norifumi Naka, Ikuo Kudawara, Takafumi Ueda, Nobuhito Araki, Tadashi Kamada, Hideki Yoshikawa
Erratum to: Gender differences in colorectal cancer survival in Japan
Kenjiro Kotake, Michio Asano, Heita Ozawa, Hirotoshi Kobayashi, Kenichi Sugihara